Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
September 29th, 2022
Brands Review Data Privacy Policies After $1.2 Million Sephora Settlement
Privacy & Data Security Chair Daniel M. Goldberg is quoted in the article, “Brands Review Data Privacy Policies After $1.2 Million Sephora Settlement” published by The Wall Street Journal. The article discusses the how companies are paying more attention to California’s data privacy laws after Sephora was penalized for alleged violations related to its targeted advertising. Daniel is quoted saying, “The biggest losers could be marketers at small-to-midsize businesses who did not realize that the regulations would apply to them. Many companies didn’t realize that the sharing of data could violate CCPA, even when they used tools like Google’s Marketing Platform that let users opt out of some targeted advertising. A separate point of contention for marketers was the fact that the CCPA’s definition of ‘sale’ included sharing consumer information with outside parties regardless of whether money is exchanged. Many companies delayed compliance because they disagree with that definition and don’t want to tell consumers that they sell data.”
The Sephora case also started new conversations about marketers’ use of behavioral data, as well as the Global Privacy Control tool. Daniel said, “California’s decision to require businesses to recognize GPC more than one year ago further complicated the compliance process, because CCPA didn’t initially contain any language related to the tool.”
Read the full article here. (Behind paywall)
Other Quoted
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
